High matrix metalloproteinase-2 expression predicts poor prognosis of colon adenocarcinoma and is associated with PD-L1 expression and lymphocyte infiltration
PeerJ · 30.06.2025 · 13 · e19550
DOI: 10.7717/peerj.19550 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, online erschienen am 30.06.2025. Verfasst von Yiyi Xiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Matrix Metalloproteinase 2, Colonic Neoplasms, B7-H1 Antigen, Adenocarcinoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin, Science and Technology Project of Tianjin Health Commission.
Abstract (Originalsprache)
Background
Colon adenocarcinoma (COAD) is a prevalent and aggressive malignancy with limited treatment options, particularly for advanced stages. While programmed death-ligand 1 (PD-L1) inhibition, has emerged as an appealing therapeutic approach for COAD, its effectiveness as a monotherapy is hindered by high tumor heterogeneity. Identifying novel therapeutic targets to boost the efficacy of PD-L1-based immunotherapy in COAD is crucial to improving clinical outcomes. Matrix metalloproteinase-2 (MMP-2), traditionally known for its role in tumor invasion, metastasis, and angiogenesis, has not been thoroughly investigated in the relationship to immunotherapy for COAD. This work aims to investigate the potential involvement of MMP-2 in the immune microenvironment of COAD and explore its possible role as a target to enhance the therapeutic efficacy of anti-PD-L1-based immunotherapy.
Methods
This study employed a comprehensive bioinformatics analysis of publicly available datasets to investigate the correlation between MMP-2 expression and PD-L1 levels in COAD. Additionally, we evaluated the impact of MMP-2 expression on patient survival and prognosis. To validate these findings, in vitro experiments were conducted to assess the effect of MMP-2 inhibition on PD-L1 expression in colon cancer cell lines. We also analyzed the association between MMP-2 expression and tumor-infiltrating lymphocytes (TILs) to elucidate the immunological landscape of COAD.
Results
Our bioinformatic analysis revealed a novel positive correlation between MMP-2 expression and PD-L1 level in COAD, indicating that higher MMP-2 level is associated with increased PD-L1 expression. Furthermore, in COAD patients, elevated MMP-2 expression was linked to poor overall survival and prognosis. In vitro experiments demonstrated that inhibiting MMP-2 significantly reduced PD-L1 expression in SW480 cells, suggesting that MMP-2 plays a regulatory function in immune evasion. In addition, a novel negative relationship between MMP-2 expression and the presence of TILs was identified, underscoring MMP-2’s potential role in modifying the COAD immunological landscape.
Conclusion
This work shows for the first time that MMP-2 not only contributes to tumor progression but also plays a critical role in the immunosuppressive microenvironment of COAD. The demonstrated association between MMP-2 and PD-L1 expression, along with its effect on TILs, indicates that MMP-2 is a promising alternative target for improving the efficacy of anti-PD-L1 immunotherapy. Targeting MMP-2 may offer a novel avenue for overcoming resistance to conventional immunotherapies, potentially improving treatment outcomes in COAD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin General Surgery Institute, Tianjin Medical University General Hospital, Tianjin, China.
- Department of General Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
- Department of Pancreatic Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
- Department of Colorectal Surgery, The Second Hospital of Tianjin Medical University, Tianjin, China.
- Department of Hepatobiliary Pancreatic Gastrointestinal Surgery, Jinhua Hospital of Wenzhou Medical University, Jinhua, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin
- Science and Technology Project of Tianjin Health Commission
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Xiao, Y., Li, G., Xie, Y., Shao, B., Hao, J., Zhu, Y., Kong, D., Qin, Y., Qin, H., Ren, S., Wang, H., Sun, C., & Wang, H. (2025). High matrix metalloproteinase-2 expression predicts poor prognosis of colon adenocarcinoma and is associated with PD-L1 expression and lymphocyte infiltration. PeerJ, 13, e19550. https://doi.org/10.7717/peerj.19550
Vancouver
Xiao Y, Li G, Xie Y, Shao B, Hao J, Zhu Y, et al. High matrix metalloproteinase-2 expression predicts poor prognosis of colon adenocarcinoma and is associated with PD-L1 expression and lymphocyte infiltration. PeerJ. 2025;13:e19550. doi:10.7717/peerj.19550
BibTeX
@article{Xiao2025,
author = {Xiao, Yiyi and Li, Guangming and Xie, Yongjie and Shao, Bo and Hao, Jingpeng and Zhu, Yanglin and Kong, Dejun and Qin, Yafei and Qin, Hong and Ren, Shaohua and Wang, Hongda and Sun, Chenglu and Wang, Hao},
title = {High matrix metalloproteinase-2 expression predicts poor prognosis of colon adenocarcinoma and is associated with PD-L1 expression and lymphocyte infiltration},
journal = {PeerJ},
year = {2025},
volume = {13},
pages = {e19550},
doi = {10.7717/peerj.19550}
}
EUVIMED